The content on this site is intended for healthcare professionals only
Prof Tak talks to ecancer at the IMProving care And Knowledge through Translational research (IMPAKT) meeting in Brussels, May 2012, about his insights in to the basis for molecular therapy. Prof Tak uses an analogy of oncogenes being the 'horses' pulling the 'cart' of cancer.
Prof Tak points out that while it looks promising to target any one of the hundreds of oncogenes which cause cancer, they essentially all result in the same 2 or 3 metabolic pathways so perhaps we should be investigating the metabolism processes instead, as a potential for a 'catch-all' treatment.
Filming Supported by Amgen
Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer
EBCC 2024: Addressing inequalities across Europe in access to innovation for patients with metastatic breast cancer
Comment: EBCC 2024 highlights
Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours
Preoperative endocrine therapy in premenopausal women leads to sparing chemotherapy in additional patients
ESMO 2023: Highlights and analysis
Adding ribociclib to endocrine therapy shows an improvement in invasive disease-free survival in HR+/HER2 BC patients
